123 iodine
IODINE I-123 is a radioactive isotope of iodine used in nuclear medicine imaging, including single photon emission computed tomography (SPECT) and X-ray computed tomography (X-Ray CT) scans. Iodine-123 is usually supplied as sodium iodide (NaI) and hypoiodite (OI−) in dilute sodium hydroxide solution, at high isotopic purity. 123I is the most suitable isotope of iodine for the diagnostic study of thyroid diseases. The half-life of approximately 13.13 h (hours) is ideal for the 24-h (hour) iodine uptake test and 123I has other advantages for diagnostic imaging thyroid tissue and thyroid cancer metastasis. The iodine is taken up by the thyroid gland and/or cancer metastasis and a gamma camera is used to functional images of the thyroid for diagnosis. Quantitative measurements of the thyroid can be performed to calculate the iodine uptake (absorption) for the diagnosis of hyperthyroidism and hypothyroidism. This is administered to a patient in capsule form, by intravenous injection, or in a drink. — NCATS
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Earliest trial started May 1, 2013 (NCT02418247)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
SMILES
[123I][123I]- Mol. weight
- 245.811195888 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIodine-123 ↗
- NCATS8YWR746RPQ ↗
- NCATS98QPV8670C ↗
Also known as
- 123i−
- 123i−
- 123 iodine
- i123
- i 123
- i 123
- i-123
- i-123
- iodide i-123
- iodide i-123
- iodide ion i-123
- iodide ion i-123
- iodine 123
- iodine 123
- iodine-123
- iodine-123
- iodine-123
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02418247 | Phase 2/Phase 3 (Phase 3) | May 1, 2013 | National Cancer Center, Korea |
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Center, Korea | Government | 1 | 1 | 1 | 2013 |